Fred Aslan
Director, Chief Executive Officer; Director, President and CEO · 8 filings · Latest: Oct 6, 2026
Artiva Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARTV | Fred Aslan | Director, Chief Executive Officer | Oct 6, 2026 | Sale | $7.20 | 23,463 | $168.9K | 1,519,606 | |
ARTV | FRED ASLAN | — | Oct 6, 2026 | Proposed Sale | $7.13 | 34,465 | $245.7K | — | |
ARTV | Fred Aslan | Director, Chief Executive Officer | Oct 5, 2026 | Sale | $6.84 | 61,696 | $421.8K | 1,543,069 | |
ARTV | Fred Aslan | Director, Chief Executive Officer | Sep 8, 2026 | Sale | $10.92 | 23,429 | $255.7K | 1,449,765 | |
ARTV | FRED ASLAN | — | Sep 8, 2026 | Proposed Sale | $11.19 | 23,429 | $262.2K | — | |
ARTV | Fred Aslan | Director, Chief Executive Officer | Sep 3, 2026 | Sale | $11.16 | 61,888 | $690.4K | 1,473,194 | |
ARTV | Fred Aslan | Director, Chief Executive Officer | May 19, 2026 | Sale | $9.01 | 27,116 | $244.3K | 1,535,082 | |
ARTV | Fred Aslan, M.D. | — | May 18, 2026 | Proposed Sale | $9.22 | 28,000 | $258.2K | — | |
ARTV | FRED ASLAN | — | Dec 15, 2025 | Proposed Sale | $3.30 | 12,749 | $42.1K | — | |
ARTV | FRED ASLAN | — | Nov 17, 2025 | Proposed Sale | $3.25 | 6,375 | $20.7K | — | |
ARTV | FRED ASLAN | — | Oct 17, 2025 | Proposed Sale | $2.77 | 25,500 | $70.6K | — | |
ARTV | FRED ASLAN | — | Aug 15, 2025 | Proposed Sale | $2.70 | 25,500 | $68.8K | — |